Please login to the form below

Not currently logged in
Email:
Password:

Cancer Research UK

This page shows the latest Cancer Research UK news and features for those working in and with pharma, biotech and healthcare.

Cancer Research UK study finds different responses to COVID-19 among cancer patients

Cancer Research UK study finds different responses to COVID-19 among cancer patients

A study funded by Cancer Research UK (CRUK) has found differing immune responses to COVID-19 among cancer patients, with certain cancer patients experiencing similar response to those without cancer, while ... Of the participants with cancer, 23 had

Latest news

More from news
Approximately 17 fully matching, plus 130 partially matching documents found.

Latest Intelligence

  • The impact of cancer on mental health during COVID-19 The impact of cancer on mental health during COVID-19

    2. Cancer Research UK. 2021. Cancer Survival Statistics For All Cancers Combined. ... Available at: Last accessed April 2021. 4. Cancer Research UK - How coronavirus is impacting cancer services in the UK.

  • Can digital communications boost behaviour change? Can digital communications boost behaviour change?

    Using a ‘one-size-fits-all’ approach can result in poor uptake or even backlash, such as Cancer Research UK being accused of fat-shaming while trying to raise awareness of ... And with 80% of people in the UK now owning smartphones, individualised

  • Building Europe’s next breakthrough biotechs Building Europe’s next breakthrough biotechs

    Its founding investors include Cambridge Innovation Capital, Babraham Research Campus through Babraham Bioscience Technologies, Roche's biotech arm Genentech, and Dr Jonathan Milner and Dr Ian Tomlinson, two of the ... life sciences campus in central

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    genetic research through to drug development in pharma, and into leadership of several successful UK biotech firms. ... She is also a Women of Influence Mentor for Cancer Research UK and a public governor for The Christie NHS Foundation Trust in

  • Combined immunotherapies – potential and pitfalls Combined immunotherapies – potential and pitfalls

    A recent review of the current landscape of clinical research in cancer immunotherapy counted more than 3, 000 trials enrolling patients, including more than 1, 000 trials evaluating combinations with ... This view is shared by Professor Charles Swanton,

More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest appointments

  • Glythera strengthens its scientific advisory board and appoints CSO Glythera strengthens its scientific advisory board and appoints CSO

    Glythera has appointed new chief scientific officer Dr Robert Lutz to lead the advancement of the UK-based biotech's antibody drug conjugate portfolio. ... Additionally, Dr Jon Roffey joins Glythera’s scientific advisory board (SAB) from Cancer

  • Storm Therapeutics strengthens its board Storm Therapeutics strengthens its board

    Workman currently serves The Institute of Cancer Researc h as its president and chief executive officer and has formerly served as head of the division of cancer therapeutics at Cancer Research ... world class cancer institute and being a founder of

  • Cancer Research UK's Karen Vousden to join BMS board Cancer Research UK's Karen Vousden to join BMS board

    Cancer Research UK's Karen Vousden is set to join Bristol-Myers Squibb’s board of directors in January. ... Vousden is currently chief scientist at Cancer Research UK, as well as serving as group leader at the Francis Crick Institute in London, will

  • Sophie Adlard joins J+D Consulting as a business analyst Sophie Adlard joins J+D Consulting as a business analyst

    She brings experience from Cancer Research UK, where she was a PhD student. ... market research and forecasting projects going forward.”.

  • Hollingsworth leaves cancer charity for ABPI Hollingsworth leaves cancer charity for ABPI

    Andrew Hollingsworth appointed policy manager at pharma industry body. Andrew Hollingsworth is to leave the third sector to join industry, moving from Cancer Research UK to the Association of the British ... He leaves his role as public affairs manager

More from appointments
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 12 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
TRIDUCIVE

Triducive are a strategic healthcare consultancy who produce communications that have practical, dynamic application that encourage behaviour change because of the...

Latest intelligence

Sharing patient stories for World Pulmonary Hypertension Day
For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...
How nature can help you manage the pressures of agency life
Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...